Lifestyle

Health & Fitness

Fitness, nutrition, recovery, sleep, mental wellness, and living better

Stories
200
stories
Sources
7
sources
Page
Page 1 of 10
Updated hourly

Why Owl Post covers Health & Fitness

Health and fitness coverage is dominated by fad protocols, supplement marketing dressed as research, and wellness influencers who swap their recommendations when the sponsorship changes.

The durable signal in this space is boring by comparison: strength training keeps appearing in longevity research, consistent sleep keeps outperforming sleep hacks, walking keeps showing up as underrated. Owl Post reads the actual research behind these claims, evaluates how solid the study design is, and surfaces what is holding up across independent replications versus what is one viral study away from being overturned.

Read the full Health & Fitness briefing

The beat covers exercise science (strength, cardio, mobility, and the research on optimal protocols), nutrition (what the evidence actually shows about diet patterns, not whatever is trending), sleep and recovery, mental health and its intersection with physical practice, and the broader wellness industry, including how to evaluate claims critically. Owl Post reads peer-reviewed research, follows the scientists and physicians doing serious work, and reads the publications that hold their reporting to an evidence standard.

Your digest adapts to how you engage with health information. If you want the science explained at the mechanism level, with the study quality assessed, that framing is available. If you want the practical implementation angle, focused on what to actually change based on the evidence, that works too. Either way, the sourcing is from people and institutions that cite their work.

A daily health and fitness digest. What the research actually shows, applied to how you actually live. The goal is not more information about wellness. It is better information, filtered by people who read the studies and know how to evaluate them.

A New Vaccine Was Designed by AI and Safely Tested on Humans

A new vaccine designed by AI is the first to be tested on humans and may protect against a wide range of coronaviruses related to SARS and COVID-19. miodrag ignjatovic/GettyImages Researchers have tested a vaccine designed to protect against a range of coronaviruses. This new vaccine was the first designed by AI to be tested on humans. The pEVAC-PS vaccine could enable protection against future mutations. The use of AI also enables the development of new vaccines much faster. However, more research is needed to determine whether it works in a more diverse population. According to an article found in the June 2026 issue of the Journal of Infection, researchers have safely tested a new vaccine designed to protect against a wide range of coronaviruses related to SARS and COVID-19. As a press release from the University of Cambridge explains, this trial is the first time that a vaccine whose active component was designed entirely by computer simulations has been tested in humans. This vaccine, developed by a team of scientists from the University of Southampton, the University of Cambridge, and DIOSynVax Ltd., is called pEVAC-PS. The technology uses a “super-antigen” designed by artificial intelligence (AI) to create protection against a wide range of viruses, even when mutations occur. Current methods for developing vaccines lack this ability, making frequent reformulations necessary to keep up with ever-changing viruses. While the vaccine was found to be safe and without significant side effects, the authors say a larger trial is needed to determine whether it can provide strong protection in a more diverse population. AI-designed vaccine tested on humans for the first time In the study, it was given to healthy volunteers in the U.K. between December 2021 and September 2023. The goal was to create a vaccine that could defend not only against current COVID-19 variants but also against future coronavirus threats that might potentially jump from animals to humans. The au

healthline.com
Twice-Monthly GLP-1 Shot Helps Manage Blood Sugar, Weight Loss in Trial

Twice-Monthly GLP-1 Shot Helps Manage Blood Sugar, Weight Loss in Trial

A new biweekly GLP-1 injection has been shown to significantly reduce blood sugar in a clinical trial. Image Credit: Hannes P Albert/picture alliance via A new GLP-1 medication demonstrated efficacy in reducing blood sugar in people with type 2 diabetes in a phase 2b clinical trial. Bofanglutide is a biweekly (once every 2 weeks) injection compared to once-weekly shots like Ozempic and Wegovy. The new biweekly GLP-1 also led to weight loss and improvement in cardiometabolic risk factors. GLP-1 drugs like Ozempic and Wegovy are groundbreaking treatments for type 2 diabetes and obesity. As other drug manufacturers join the GLP-1 race, Gan & Lee Pharmaceuticals in Beijing, China, is developing a novel biweekly GLP-1 for weight loss. In a phase 2b randomized clinical trial, bofanglutide demonstrated a strong efficacy in reducing blood sugar in people with type 2 diabetes. If approved, a biweekly shot could offer an alternative to once-weekly GLP-1 injections for the needle-averse. The results of the trial were published in Annals of Internal Medicine on June 30. Biweekly GLP-1 lowers blood sugar, aids weight loss Bofanglutide is a biweekly (once every 2 weeks) injection, unlike most other GLP-1 medications (i.e., Ozempic, Wegovy, or Mounjaro), which are once-weekly shots. The phase 2b clinical trial of bofanglutide included 272 adults with type 2 diabetes, with an average age of 50.8, from 37 sites across China. The participants were divided into five treatment groups: bofanglutide 12 mg (biweekly) bofanglutide 18 mg (biweekly) bofanglutide 24mg (biweekly) bofanglutide 24mg (once weekly) semaglutide 1mg (once weekly) The primary measurement the researchers focused on was HbA1c levels from the baseline to the 24-week follow-up. At the end of 24 weeks, all bofanglutide groups showed significant reductions in blood sugar levels. Participants taking bofanglutide experienced weight loss and improvements in various cardiometabolic risk factors. How does bofanglutide compare t

healthline.com

Sitting Too Much Raises Cancer Risk, But Short Bursts of Light Activity May Help

New research shows that prolonged periods of sitting or lying down could increase the risk of certain cancers. Image Credit: Justin Paget/Getty Images A new study found that prolonged sedentary behaviors can raise the risk of various cancers, including colorectal, pancreatic, and breast cancer. Replacing just 1 hour of prolonged sedentary behavior per day with light physical activity reduced the risk of cancer death by 12%. While the findings don’t establish causality, they can help guide personalized strategies to break up sitting time. Sedentary behaviors are ubiquitous in modern life. Many jobs require long periods of sitting, and many people enjoy streaming television shows and movies or playing video games. Whatever the reason, a sedentary lifestyle may raise the risk of various health issues. A new study published in PLOS Medicine on July 2 found that prolonged sedentary behavior could increase the risk of many types of cancer. However, the findings also indicate that breaking up your sitting time, even with just an hour of light activity, can greatly reduce the risk. “A sedentary lifestyle can lead to a person becoming overweight,” said David Yashar, MD, hematologist-medical oncologist of MemorialCare Todd Cancer Institute at Long Beach Medical Center in Long Beach, CA. Yashar wasn’t involved in the study. “We know that an increased amount of fat causes inflammation, which is a known risk factor for cancer. Obesity has also been associated with the development of colorectal cancer,” Yashar told Healthline. Prolonged sitting raises cancer-related death risk by 10% The study analyzed data from 91,292 participants in the UK Biobank. Each participant had worn an activity monitor for 7 days and was followed for an average of 12.38 years afterward. During the study, activity was categorized in the following ways: prolonged sedentary (bouts of at least 30 minutes, with at least 90% of the time sedentary) interrupted sedentary (lasted less than 30 minutes or was brok

healthline.com

Get Health & Fitness delivered to your inbox

Owl Post delivers a personalized health & fitness digest every morning, curated by AI, written in your voice.

Get your free digest
More in Lifestyle
Explore other beats
From the Owl Post blog